Scientific Programme
ECIO 2010 Final Programme/Pocket Guide (1.10 MB)
ECIO 2010 Programme at a glance (30 KB)
Wednesday | Thursday | Friday | Saturday
Wednesday, July 21 Top
08:30-10:00
TF 101 Technical Focus Session Main Auditorium
State-of-the-art techniques in tumour ablation
Moderators: J.H. Peregrin (Prague/CZ), P. Rossi (Rome/IT)
101.1 Focused ultrasound
G. Di Candio (Pisa/IT)
101.2 Chemical ablation
M. Kuang (Guangzhou/CN)
101.3 Radiofrequency ablation
N. Goldberg (Boston, MA/US)
101.4 Microwave ablation
L. Crocetti (Pisa/IT)
101.5 Cryoablation
D.J. Breen (Southampton/UK)
101.6 Irreversible electroporation
T.K. Helmberger (Munich/DE)
101.7 Light activated therapy
R. Lencioni (Pisa/IT)
10:30-11:30
TF 201 Technical Focus Session Main Auditorium
Advances in image guidance
Moderators: G. Cornalba (Milan/IT),
M. Szczerbo-Trojanowska (Lublin/PL)
201.1 Ultrasound
L. Solbiati (Busto Arsizio/IT)
201.2 CT
T. De Baère (Villejuif/FR)
201.3 MR imaging
P. Pereira (Heilbronn/DE)
201.4 Volumetric approaches in CT
D. Cioni (Pisa/IT)
201.5 Stereotaxy and navigation
R. Bale (Innsbruck/AT)
10:30-11:30
WS 202 Workshop Sala Verde
New options in regional cancer treatment
Moderator: R. Lencioni (Pisa/IT)
202.1 Technical introduction
J.F. Pingpank (Pittsburgh, PA/US)
202.2 W. Prevoo (Amsterdam/NL)
202.3 J.S. Zager (Tampa, FL/US)
11:30-12:15
SY 301 Satellite Symposium Main Auditorium
Bracco
Role of contrast enhanced ultrasound in the
diagnosis and treatment of tumours
Moderator: E. Leen (London/UK)
301.1 Quantification of tumour microvascularity using CEUS
modality for monitoring anti-angiogenic therapies
E. Leen (London/UK)
301.2 CEUS-guided percutaneous radiofrequency ablation of
breast cancer liver metastases
M.F. Meloni (Monza/IT)
301.3 New perspectives in interventional contrast ultrasound
imaging: 3D contrast and multi-modality fusion imaging
L. Solbiati (Busto Arsizio/IT)
12:15-13:00
SY 302 Satellite Symposium Main Auditorium
CeloNova
Targeted embolization in liver pathologies with
Embozene™ Color-Advanced Microspheres
Moderator: J.G. Caridi (Gainesville, FL/US)
302.1 Multipurpose use of Embozene™ Color-Advanced
Microspheres in clinical practice
F. Orsi (Milan/IT)
302.2 The concept of liver tumor embolization with 40 µm
Embozene™ Color-Advanced Microspheres
T.K. Helmberger (Munich/DE)
302.3 Portal vein embolization: experience with various spherical
embolic agents
M. Wallace (Houston, TX/US)
14:00-15:30
EM 401 ECIO meets ESMO Main Auditorium
Current concepts in the treatment of colorectal
hepatic metastases
Moderators: A. Falcone (Pisa/IT), V. Mazzaferro (Milan/IT)
401.1 Outcomes of surgical resection
V. Mazzaferro (Milan/IT)
401.2 Current chemotherapy regiments in first and second line
A. Falcone (Pisa/IT)
401.3 Chemotherapy of non-resectable liver metastases
in advanced colorectal cancer
H.-J. Schmoll (Halle/DE)
401.4 Outcomes of percutaneous ablation
L. Solbiati (Busto Arsizio/IT)
401.5 Radioembolization
J.I. Bilbao (Pamplona/ES)
401.6 Conventional chemoembolization and drug-eluting beads
R.C. Martin (Louisville, KY/US)
14:00-15:30
WS 402 Workshop Sala Verde
Intra-arterial treatments: technical tips
(meet-the-expert: case discussion)
Moderator: J.G. Caridi (Gainesville, FL/US)
402.1 Y. Arai (Tokyo/JP)
402.2 M. Grosso (Cuneo/IT)
402.3 F. Orsi (Milan/IT)
402.4 C. Vignali (Lido di Camaiore/IT)
16:00-17:30
CF 501 Clinical Focus Session Main Auditorium
Lung tumours
Moderators: T.K. Helmberger (Munich/DE), U. Pastorino
(Carrara/IT)
501.1 Clinical overview and surgical management
U. Pastorino (Milan/IT)
501.2 Ablation outcomes: primary lung cancer
L. Crocetti (Pisa/IT)
501.3 Ablation outcomes: metastases
T. De Baère (Villejuif/FR)
501.4 Complications of lung ablation
G. Carrafiello (Varese/IT)
501.5 Stereotactic body radiation therapy (SBRT)
C. Greco (Pisa/IT)
501.6 Intra-arterial chemoembolization
T. Vogl (Frankfurt/DE)
16:00-17:30
WS 502 Workshop Sala Verde
TACE with drug eluting beads (meet-the-expert:
case discussion)
Moderator: G. Cornalba (Milan/IT)
502.1 Technical introduction
H. Langenberger (Vienna/AT)
502.2 K. Malagari (Athens/GR)
502.3 F. Melchiorre (Milan/IT)
502.4 A. Nicolini (Milan/IT)
16:00-17:30
WS 503 Workshop Sala 4
Patient preparation, informed consent and
anaesthesiology care
Moderator: I. Battyány (Pécs/HU)
503.1 M. Abdel-Rehim (Clichy/FR)
503.2 E. Perez-Rojas (Miami, FL/US)
17:30-18:00
SY 601 Satellite Symposium Sala Verde
Covidien
RFA and MWA: The Power of Choice
Moderator: J. Case (Boulder, CO/US)
601.1 Clinical applications of multiple RFA electrode technology
A. Gillams (London/UK)
601.2 MWA of liver metastases
T. Lorentzen (Herlev/DK)
17:30-18:00
SY 602 Satellite Symposium Main Auditorium
Terumo
Pre Radioembolization coiling, the added value of
Hydrocoils
Moderator: G. Maleux (Leuven/BE)
602.1 Watertight GDA embolization
S.C. Rose (San Diego, CA/US)
602.2 Azur, One year experience at Grosshadern Hospital
R.-T. Hoffmann (Munich/DE)
Thursday, July 22 Top
08:30-10:00
CF 701 Clinical Focus Session Main Auditorium
Early-stage hepatocellular carcinoma
Moderators: M. Colombo (Milan/IT), D.S.-K. Lu
(Los Angeles, CA/US)
701.1 Diagnostic and staging criteria
M. Colombo (Milan/IT)
701.2 Resection vs. transplantation
P. Majno (Geneva/CH)
701.3 Transplantation after interventional downstaging
P. De Simone (Pisa/IT)
701.4 Outcomes of percutaneous ablation
L. Crocetti (Pisa/IT)
10:30-11:30
CF 801 Clinical Focus Session Main Auditorium
Intermediate-advanced hepatocellular carcinoma
Moderators: J.I. Bilbao (Pamplona/ES), J.-F.H. Geschwind
(Baltimore, MD/US)
801.1 Conventional TACE vs. TACE with drug eluting beads
R. Lencioni (Pisa/IT)
801.2 Outcomes of radioembolization
R. Salem (Chicago, IL/US)
801.3 Combining intra-arterial and systemic treatments
J.-F.H. Geschwind (Baltimore, MD/US)
11:30-12:15
SY 901 Satellite Symposium Main Auditorium
Terumo
Drug-eluting beads: what's new?
Moderator: M. Burrel (Barcelona/ES)
901.1 Results from a prospective randomized comparison of
chemoembolization with DC Bead versus bland
embolization for HCC
K. Malagari (Athens/GR)
901.2 Irinotecan-eluting beads as a neoadjuvant treatment of
colorectal liver metastases in resectable patients
E.A. O’Grady (Liverpool/UK)
901.3 DC Beads for the treatment of liver metastases from
melanoma: new application?
P. Pereira (Heilbronn/DE)
901.4 DC Beads for the treatment of liver metastases from occular
Melanoma : tips and tricks from more than 50 patients
experience in Ferrara center
C. Aliberti (Lagosanto/IT)
12:15-13:00
SY 902 Satellite Symposium Main Auditorium
Biocompatibles
LC/DC Bead - how to select patients and optimise
outcomes
Moderator: R. Lencioni (Pisa/IT)
902.1 Technical aspects of hepatocellular carcinoma. How to
do it.
J.G. Caridi (Gainesville, FL/US)
902.2 Technical aspects of metastatic diseases. How to do it.
G. Narayanan (Miami, FL/US)
902.3 DC Bead in metastatic disease. DEBIRI in combination
with systemic chemotherapy: the optimal management
of liver dominant metastatic disease
R.C. Martin (Louisville, KY/US)
14:00-16:00
EM 1001 ECIO meets ILCA Main Auditorium
Diagnosis and treatment of hepatocellular
carcinoma: ongoing challenges
Moderators: R. Lencioni (Pisa/IT), P. Majno (Geneva/CH)
1001.1 When is biopsy needed and image not enough? Novel
pathology criteria
M. Roncalli (Milan/IT)
1001.2 HCC staging, evaluation of treatment efficacy and
detection of recurrence
C. Ayuso (Barcelona/ES)
1001.3 Surgery and interventional radiology: competitors or
complementary
P. Majno (Geneva/CH)
1001.4 Is radiotherapy back for the treatment of HCC?
T.K. Helmberger (Munich/DE)
14:00-15:30
WS 1002 Workshop Sala Verde
Interventional treatment in advanced cancer
stages (meet-the-expert: case discussion)
Moderator: T. Torri (Carrara/IT)
1002.1 D. Gasparini (Udine/IT)
1002.2 M.G. Mack (Frankfurt/DE)
1002.3 A. Lunardi (Carrara/IT)
1002.4 V. Válek (Brno/CZ)
16:30-17:30
HL 1101 Honorary Lecture Main Auditorium
Laudation: R. Lencioni (Pisa/IT)
1101.1 Evolving strategies in the treatment of hepatocellular
carcinoma
V. Mazzaferro (Milan/IT)
17:30-18:15
SY 1201 Satellite Symposium Main Auditorium
AngioDynamics
Irreversible electroporation: the next frontier for
focal ablative therapy
Early human experience at three centers
Moderator: R. Lencioni (Pisa/IT)
1201.1 IRE: moving from bench investigation to clinical
experience
R. Lencioni (Pisa/IT)
1201.2 The University of Miami experience with the Nanoknife
G. Narayanan (Miami, FL/US)
1201.3 Non-thermal ablation using irreversible electroporation
(IRE): initial U.S. clinical experience
R.C. Martin (Louisville, KY/US)
Friday, July 23 Top
08:30-10:00
CF 1301 Clinical Focus Session Main Auditorium
Kidney tumours
Moderators: J.G. Caridi (Gainesville, FL/US)
T.K. Helmberger (Munich/DE)
1301.1 Clinical overview and surgical management
U.-B. Liehr (Magdeburg/DE)
1301.2 Outcomes of RF ablation
A. Veltri (Orbassano/IT)
1301.3 Cryoablation vs. RF ablation
D.J. Breen (Southampton/UK)
1301.4 Embolization
J.G. Caridi (Gainesville, FL/US)
1301.5 Current role of interventions in metastatic kidney tumours
G. Carrafiello (Varese/IT)
08:30-10:00
WS 1302 Workshop Sala Verde
Radioembolization (meet-the-expert: case
discussion)
Moderator: D. Vorwerk (Ingolstadt/DE)
1302.1 Technical introduction
J.I. Bilbao (Pamplona/ES)
1302.2 R. Golfieri (Bologna/IT)
1302.3 T.F. Jakobs (Munich/DE)
1302.4 R. Salem (Chicago, IL/US)
08:30-10:00
WS 1303 Workshop Sala 4
How to start a practice in tumour ablation
Moderator: P. Pereira (Heilbronn/DE)
1303.1 C.T. Sofocleous (New York, NY/US)
10:30-11:30
TB 1401 Multidisciplinary tumour board Main Auditorium
Liver cancer
Moderator: R. Lencioni (Pisa/IT)
Panellists:
M. Brunetto (Pisa/IT)
U. Cillo (Padua/IT)
J.-F.H. Geschwind (Baltimore, MD/US)
T.K. Helmberger (Munich/DE)
D.S.-K. Lu (Los Angeles, CA/US)
V. Mazzaferro (Milan/IT)
10:30-11:30
WS 1402 Workshop Sala Verde
Extrahepatic ablation: technical tips
(meet-the-expert: case discussion)
Moderator: N. Goldberg (Boston, MA/US)
1402.1 D.J. Breen (Southampton/UK)
1402.2 A. Gillams (London/UK)
1402.3 C.T. Sofocleous (New York, NY/US)
11:30-12:15
SY 1501 Satellite Symposium Main Auditorium
Sirtex
Broadening the horizon: why choose
radioembolization over other options?
Moderator: G. Maleux (Leuven/BE)
1501.1 The compelling evidence base for unresectable liver
metastases
T.F. Jakobs (Munich/DE)
1501.2 Expanding the cohort of patients with primary liver
tumours receiving radioembolization
J.I. Bilbao (Pamplona/ES)
12:15-13:00
SY 1502 Satellite Symposium Main Auditorium
Siemens
Image-guided solutions for
interventional oncology
Minimally invasive, maximally effective
Moderator: R. Lencioni (Pisa/IT)
1502.1 The benefits of Artis zeego during liver tumour treatment
T.F. Jakobs (Munich/DE)
1502.2 New approaches in cancer diagnostics and CT-guided
interventions
A. Schmid (Erlangen/DE)
14:00-16:00
EM 1601 ECIO meets WCIO Main Auditorium
Emerging technologies and synergies in
interventional oncology
Moderators: M. Brunner (Chicago, IL/US), R. Lencioni
(Pisa/IT)
1601.1 Advanced thermal systems: are bigger burns possible?
C. Brace (Madison, WI/US)
1601.2 Thermal synergies: heat, drugs and small molecules
N. Goldberg (Boston, MA/US)
1601.3 New cryo technology and cryoimmunotherapy
C.T. Sofocleous (New York, NY/US)
1601.4 Irreversible electroporation
R. Lencioni (Pisa/IT)
1601.5 Oncolytic virus
S.C. Rose (San Diego, CA/US)
1601.6 Targeting tumour metabolism with intra-arterial therapy
J.-F.H. Geschwind (Baltimore, MD/US)
14:00-15:30
WS 1602 Workshop Sala Verde
Liver ablation: technical tips (meet-the-expert:
case discussion)
Moderator: W. Lees (London/UK)
1602.1 T. Albrecht (Berlin/DE)
1602.2 M. Bezzi (Rome/IT)
1602.3 F. Izzo (Naples/IT)
1602.4 D.S.-K. Lu (Los Angeles, CA/US)
16:30-18:00
CF 1701 Clinical Focus Session Main Auditorium
Image-guided ablation: new frontiers
Moderators: R. Bale (Innsbruck/AT), L. Crocetti
(Pisa/IT)
1701.1 Head and neck
M.G. Mack (Frankfurt/DE)
1701.2 Prostate
G. Onik (Celebration, FL/US)
1701.3 Breast
S.O. Pfleiderer (Bremerhaven/DE)
1701.4 Pelvis and retroperitoneum
A. Gillams (London/UK)
1701.5 Novel areas of investigation
K.R. Thomson (Melbourne, VIC/AU)
1701.6 Novel areas of investigation
M. Pech (Magdeburg/DE)
16:30-18:00
WS 1702 Workshop Sala Verde
Complications of image-guided ablation
(meet-the-expert: case discussion)
Moderator: C. Ferro (Genoa/IT)
1702.1 T. De Baère (Villejuif/FR)
1702.2 A. Gangi (Strasbourg/FR)
1702.3 V. Válek (Brno/CZ)
1702.4 A. Venkatesan (Bethesda, MD/US)
18:00-18:30
SY 1801 Satellite Symposium Main Auditorium
Celon
RFITT - The Celon Method
Large homogeneous ablation volumes by use of
multiapplicator devices
Moderator: T. Albrecht (Berlin/DE)
1801.1 Multipolar RFA of liver metastases - principles and clinical
results
T. Albrecht (Berlin/DE)
18:00-18:30
SY 1802 Satellite Symposium Sala Verde
Bayer Schering Pharma
Managing intermediate- and advanced-stage HCC
patients
Moderator: T. De Baère (Villejuif/FR)
1802.1 Building on the experience with sorafenib in
advanced-stage HCC: an hepatologist's perspective
M. Colombo (Milan/IT)
1802.2 Evolving strategies in intermediate-stage HCC: where are
we now?
T. De Baère (Villejuif/FR)
Saturday, July 24 Top
08:30-10:00
TF 1901 Technical Focus Session Main Auditorium
Advances in cancer imaging integrating
interventional oncology
Moderators: C. Della Pina (Pisa/IT), O. Pellerin
(Paris/FR)
1901.1 Dynamic MRI
C. Della Pina (Pisa/IT)
1901.2 Diffusion MRI
S. Gourtsoyianni (Iraklion/GR)
1901.3 Tissue specific MR contrast imaging
P. Reimer (Karlsruhe/DE)
1901.4 Navigation, targeting and monitoring
A. Venkatesan (Bethesda, MD/US)
1901.5 Segmentation, planning and follow-up assessments
D. Cioni (Pisa/IT)
10:30-11:30
CF 2001 Clinical Focus Session Main Auditorium
Bone tumours
Moderators: A. Gangi (Strasbourg/FR), A.D. Kelekis
(Athens/GR)
2001.1 Bone ablation: indications and patient selection
A.D. Kelekis (Athens/GR)
2001.2 Treatment of bone metastases
A. Manca (Candiolo/IT)
2001.3 Combined ablation and cementoplasty
R.-T. Hoffmann (Munich/DE)
2001.4 Neoadjuvant embolization
C. Plank (Vienna/AT)
Back
print page
Top
Copyright © CIRSE Foundation (Cardiovascular and Interventional Radiological Society of Europe)